UK Supreme Court ruling on HGS TNF patent unifies EU welcome for arm-waving claims
This article was originally published in Scrip
Executive Summary
On its first ever ruling on an IP related case, the UK's Supreme Court has upheld the validity of a patent filed by Human Genome Science and challenged by Lilly. The case is good news for biotech and brings the UK patent system into line with Europe, say lawyers.